Matches in Wikidata for { <http://www.wikidata.org/entity/Q80869897> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q80869897 description "artículu científicu espublizáu n'ochobre de 2004" @default.
- Q80869897 description "im Oktober 2004 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80869897 description "scientific article published on 01 October 2004" @default.
- Q80869897 description "wetenschappelijk artikel" @default.
- Q80869897 description "наукова стаття, опублікована в жовтні 2004" @default.
- Q80869897 name "Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?" @default.
- Q80869897 name "Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?" @default.
- Q80869897 type Item @default.
- Q80869897 label "Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?" @default.
- Q80869897 label "Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?" @default.
- Q80869897 prefLabel "Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?" @default.
- Q80869897 prefLabel "Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?" @default.
- Q80869897 P1433 Q80869897-13D0E186-01BE-4D04-A8D3-DDC2E16E46BE @default.
- Q80869897 P1476 Q80869897-17EF360A-2B40-43F3-8675-9BF403DA2182 @default.
- Q80869897 P2093 Q80869897-077CEACA-134F-4519-B235-123FF744E87A @default.
- Q80869897 P2093 Q80869897-75BC1235-4BEC-4F02-9B64-78B7BC434402 @default.
- Q80869897 P2093 Q80869897-9CA2C936-717C-4D9C-A0D1-85F31F1B5BAB @default.
- Q80869897 P2093 Q80869897-A24975F4-06AB-43C9-8923-78620000CD1E @default.
- Q80869897 P2093 Q80869897-CF0C34FB-7E2F-4BD3-851F-A25D7B2923C6 @default.
- Q80869897 P304 Q80869897-25B30FD2-25C3-467C-9517-25D5BECD9620 @default.
- Q80869897 P31 Q80869897-836FC13E-1B9D-4FD8-B068-29CBE897B437 @default.
- Q80869897 P433 Q80869897-E11BA3CD-2C4C-401C-980C-ADB77F3B2257 @default.
- Q80869897 P478 Q80869897-F9CEEA31-5728-4BB3-B0B2-526E5AA466FA @default.
- Q80869897 P577 Q80869897-027F93AF-A3B3-4D1C-8D94-1C2FA29DEE14 @default.
- Q80869897 P698 Q80869897-E82F45B1-0417-414F-BD83-3BFC608FF325 @default.
- Q80869897 P698 15487967 @default.
- Q80869897 P1433 Q7750866 @default.
- Q80869897 P1476 "Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?" @default.
- Q80869897 P2093 "Christine Y Lu" @default.
- Q80869897 P2093 "James V Bertouch" @default.
- Q80869897 P2093 "Kenneth M Williams" @default.
- Q80869897 P2093 "Lyn March" @default.
- Q80869897 P2093 "Richard O Day" @default.
- Q80869897 P304 "457; discussion 457-8" @default.
- Q80869897 P31 Q13442814 @default.
- Q80869897 P433 "8" @default.
- Q80869897 P478 "181" @default.
- Q80869897 P577 "2004-10-01T00:00:00Z" @default.
- Q80869897 P698 "15487967" @default.